These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 3097664)

  • 1. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
    Yee B
    Prog Clin Biol Res; 1986; 225():175-88. PubMed ID: 3097664
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study.
    Fedele L; Marchini M; Bianchi S; Baglioni A; Bocciolone L; Nava S
    Obstet Gynecol; 1990 Jul; 76(1):79-84. PubMed ID: 2113661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of LHRH agonist therapy in the treatment of endometriosis (English experience).
    Jelley RY; Magill PJ
    Prog Clin Biol Res; 1986; 225():227-38. PubMed ID: 3097668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY; Spellacy WN; Dmowski WP; Gambrell RD; Greenblatt RB; Girard Y; Lemay A; Mishell DR; Nagamani M; Pepperell RJ
    Prog Clin Biol Res; 1990; 323():253-67. PubMed ID: 2106142
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
    Franssen AM; Rolland R; Chadha DR; Willemsen WN; Vemer HM
    Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
    Trabant H; Widdra W; de Looze S
    Prog Clin Biol Res; 1990; 323():357-82. PubMed ID: 2106146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).
    Franssen AM; Kauer FM; Rolland R; Zijlstra JA; Willemsen WN; van 't Veen AJ
    Prog Clin Biol Res; 1986; 225():201-10. PubMed ID: 3097666
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
    Cirkel U; Schweppe KW; Ochs H; Schneider HP
    Prog Clin Biol Res; 1986; 225():189-99. PubMed ID: 3097665
    [No Abstract]   [Full Text] [Related]  

  • 9. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
    Dmowski WP; Radwanska E; Binor Z; Tummon I; Pepping P
    Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with danazol treatment of endometriosis and mastopathy].
    Pavelka R; Schneider WH
    Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid levels during treatment of endometriosis.
    Hirschowitz JS; Soler NG; Wortsman J
    Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.
    Tummon IS; Ali A; Pepping ME; Radwanska E; Binor Z; Dmowski WP
    Fertil Steril; 1988 May; 49(5):792-6. PubMed ID: 3129312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hormonal effect of danazol in women with regular menstrual cycles and in those with ovarian deficiency].
    Bertaglia MG; Miragoli A; Dorato F; Nencioni T
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):173-80. PubMed ID: 6779692
    [No Abstract]   [Full Text] [Related]  

  • 14. [The new synthetic gestagen danazol in the treatment of endometriosis, fibrosystic disease of the breast and prolonged primary infertility (author's transl)].
    Goebel R; Rjosk HK
    Geburtshilfe Frauenheilkd; 1978 Nov; 38(11):932-40. PubMed ID: 152220
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
    Minaguchi H; Uemura T; Shirasu K
    Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
    Lemay A; Maheux R; Jean C; Faure N
    Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
    [No Abstract]   [Full Text] [Related]  

  • 18. Buserelin versus danazol in the treatment of endometriosis-associated infertility.
    Fedele L; Bianchi S; Arcaini L; Vercellini P; Candiani GB
    Am J Obstet Gynecol; 1989 Oct; 161(4):871-6. PubMed ID: 2529770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
    Rannevik G
    Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic findings and hormonal patterns in the treatment of endometriosis by danazol.
    Tolino A; Romano L; Chiacchio G; Ronsini S; Montemagno U
    Acta Eur Fertil; 1987; 18(2):85-9. PubMed ID: 2957884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.